Synchrony exec exercises options, sells 5,456 shares

Rhea-AI Filing Summary

Synchrony Financial executive Alberto Casellas, EVP and CEO–Health & Wellness, exercised 5,456 employee stock options for common stock at an exercise price of $33.53 per share on August 13, 2026, then sold the resulting 5,456 common shares at $80.00 per share in a market transaction.

The option exercise reduced his reported option position from a 2018 grant to 5,455 options remaining. All reported trades were made under a Rule 10b5-1 trading plan adopted on October 27, 2025.

Insider Trade Summary 10b5-1

Exercise and Sale: 5,456 shares ($254K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Casellas Alberto

Role See remarks

Sold 5,456 shs ($436K)

Approx. gross sale proceeds $436K

Approx. exercise cost $183K

Approx. pre-tax spread $254K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy) F1, F2	5,456	$0.00	$0.00
Exercise	Common Stock F1	5,456	$33.53	$183K
Sale	Common Stock F1	5,456	$80.00	$436K

Holdings After Transaction: Employee Stock Option (right to buy) — 5,455 contracts (Direct); Common Stock — 50,512 shares (Direct)

Footnotes (2)

1. F1. These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 27, 2025.
2. F2. The Reporting Person was awarded 10,911 employee stock options on April 1, 2018, which vested in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.

Key Figures

Options exercised: 5,456 options Option exercise price: $33.53 per share Shares sold: 5,456 shares +3 more

6 metrics

Options exercised 5,456 options Employee stock options exercised on August 13, 2026

Option exercise price $33.53 per share Exercise price for 5,456 employee stock options

Shares sold 5,456 shares Common stock sold on August 13, 2026 after option exercise

Sale price $80.00 per share Per-share price for 5,456 SYF common shares sold

Options remaining 5,455 options Employee stock options remaining from the 2018 grant after exercise

Original option grant 10,911 options Employee stock options awarded on April 1, 2018

Key Terms

Rule 10b5-1 trading plan, Employee Stock Option (right to buy), derivative security

3 terms

Rule 10b5-1 trading plan regulatory

"These transactions were made pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Employee Stock Option (right to buy) financial

"security_title: Employee Stock Option (right to buy)"

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Synchrony Financial (SYF) executive Alberto Casellas report in this Form 4?

Alberto Casellas reported exercising 5,456 stock options at $33.53 per share and immediately selling 5,456 common shares at $80.00 per share on August 13, 2026, as part of his compensation-related equity holdings.

How many Synchrony Financial (SYF) options did Alberto Casellas exercise and at what price?

He exercised 5,456 employee stock options for Synchrony Financial common stock at an exercise price of $33.53 per share. These options were part of a 2018 grant that vested in five annual installments beginning on April 1, 2019.

At what price did Alberto Casellas sell Synchrony Financial (SYF) shares on August 13, 2026?

He sold 5,456 shares of SYF common stock at $80.00 per share on August 13, 2026. The sale followed the same-day option exercise that generated those shares, reflecting a typical exercise-and-sell transaction sequence.

Were Alberto Casellas’s Synchrony Financial (SYF) trades made under a Rule 10b5-1 plan?

Yes. The filing states that all reported transactions were made pursuant to a Rule 10b5-1 trading plan adopted by Alberto Casellas on October 27, 2025, indicating they followed a pre-arranged trading schedule.

How many Synchrony Financial (SYF) options from the 2018 grant remain after these transactions?

After exercising 5,456 options, the filing reports 5,455 options remaining from the April 1, 2018 grant. The original grant was 10,911 employee stock options, vesting in five equal annual installments of 20% each.

What role does Alberto Casellas hold at Synchrony Financial (SYF) in this Form 4?

He is identified as an officer of Synchrony Financial, serving as EVP, CEO–Health & Wellness. The reported transactions relate to equity awards and trades associated with his executive compensation package and ownership position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 04:03 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Casellas Alberto

(Last) (First) (Middle)

777 LONG RIDGE ROAD

C/O CORPORATE SECRETARY

(Street)

STAMFORD CONNECTICUT 06902

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Synchrony Financial [ SYF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2026		M		5,456(1)	A	$33.53	55,968	D
Common Stock	08/13/2026		S		5,456(1)	D	$80	50,512	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$33.53	08/13/2026		M			5,456(1)	(2)	04/01/2028	Common Stock	5,456	$0	5,455	D

Explanation of Responses:

1. These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 27, 2025.

2. The Reporting Person was awarded 10,911 employee stock options on April 1, 2018, which vested in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.

Remarks:

EVP, CEO--Health & Wellness

	/s/ Danielle Do as attorney in fact	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)